Dr. Evans served as a Senior Analyst covering the US pharmaceuticals industry at Sanford C. Bernstein & Co., LLC, from 1998 until 2006. While there, he was named to the Institutional Investor’s All-America Research Team. He was also ranked first amongst his peers for drug stock selection and amongst the top 20 stock pickers globally by Bloomberg.
Previously, he was a member of senior management at Roche Pharmaceuticals, where he served as head of Business Development and Strategic Planning, Product Director for the company’s injectable anesthetics, and most recently as Vice President, Business Policy and Account Management. In this capacity, he was responsible for Roche’s commercial interactions with large buyers, managed-care organizations and governments. His responsibilities included account management, customer marketing, pricing, contract administration, pharmacoeconomics, and distribution.
Dr. Evans earned a doctorate in Veterinary Medicine from North Carolina State University in 1988 and a Master’s of Public and Private Management from Yale University in 1991. His work has been highlighted in various major media outlets, including The Wall Street Journal, Barron’s, The New York Times, Fortune, CNN, CBS, and Frontline.